MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 179 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2017. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,302,895 | +117.1% | 39,232 | +106.3% | 0.01% | +66.7% |
| Q3 2022 | $600,000 | -19.8% | 19,019 | -48.2% | 0.00% | +50.0% |
| Q4 2021 | $748,000 | -12.6% | 36,686 | -0.2% | 0.00% | -85.7% |
| Q2 2020 | $856,000 | +124.1% | 36,745 | -19.2% | 0.01% | +40.0% |
| Q1 2020 | $382,000 | -57.4% | 45,502 | -50.4% | 0.01% | +100.0% |
| Q4 2019 | $897,000 | +60.8% | 91,795 | +56.1% | 0.01% | 0.0% |
| Q3 2019 | $558,000 | -20.2% | 58,796 | -0.0% | 0.01% | -28.6% |
| Q2 2019 | $699,000 | +46.8% | 58,811 | +117.4% | 0.01% | +40.0% |
| Q1 2019 | $476,000 | -47.8% | 27,047 | -48.5% | 0.01% | -54.5% |
| Q4 2018 | $912,000 | +64.9% | 52,515 | +32.9% | 0.01% | +10.0% |
| Q4 2017 | $553,000 | +88.7% | 39,524 | +112.8% | 0.01% | +66.7% |
| Q2 2017 | $293,000 | – | 18,574 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |